Rivaroxaban Tablet belongs to Medicare Class B drugs, and the out-of-pocket payment percentage is around 10% to 30%. This kind of drug requires patients to pay a certain percentage of the cost first, and then it will be included in the coverage of the basic medical insurance fund and paid according to the payment standard of the basic medical insurance. Generally speaking, the drugs that can be included in the scope of basic medical insurance mainly include two different types: Class A and Class B. Class A drugs can be reimbursed according to the reimbursement rate of 100%, while Class B drugs need to be paid partly out of pocket. Rivaroxaban belongs to category B and is mainly used after joint replacement surgery and deep vein thrombosis. If the patient has medical insurance and meets the reimbursement conditions of medical insurance, then it can be reimbursed, but the specific reimbursement rate is related to the local policy. Although rivaroxaban tablets are medical insurance drugs, but when taking the time to choose according to the actual situation, it is recommended that patients in the guidance of the doctor to take medication, to avoid adverse reactions and so on.